⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Alpha-Synuclein Strains in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies (S26.006)

George T. Kannarkat Rebecca Zack R. Tyler Skrinak James F. Morley Roseanne Davila‐Rivera Sanaz Arezoumandan Katherine Dorfman Kelvin C. Luk Daniel Weintraub Thomas F. Tropea Edward B. Lee Virginia Lee David J. Irwin Rizwan Akhtar Alice Chen‐Plotkin

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study tested whether monoclonal antibodies generated against in vitro alpha-synuclein (aSyn) strains can serve as biomarkers in human biofluids.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kannarkat et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db643587677435 https://doi.org/10.1212/wnl.0000000000206365

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alpha-Synuclein Conformations in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies2024
2α-Synuclein Conformations in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies2024 · 2 citations
3Salivary Alpha-Synuclein to Differentiate Parkinson’s Disease from Drug Induced Parkinsonism and Controls Using ELISA2024
4Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's diseaseOriginal Research · 2017 · 63 citations
5Detection of α-synuclein aggregates in synucleinopathies: current approaches, biomarkers and challengesReview · 2026 · 1 citations